US Patent

US11013761 — Pharmaceutical compositions

Formulation · Assigned to Vifor Fresenius Medical Care Renal Pharma Ltd · Expires 2028-11-13 · 2y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions for oral administration that contain iron oxy-hydroxide in high loading.

USPTO Abstract

Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.

Drugs covered by this patent

ferric-oxyhydroxide (FERRIC OXYHYDROXIDE)

Patent Metadata

Patent number: US11013761
Jurisdiction: US
Classification: Formulation
Expires: 2028-11-13
Drug substance claim: No
Drug product claim: Yes
Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.